Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Bayer Pharma Aktiengesellschaft
Bayer Pharma Aktiengesellschaft xfc xdf

Bayer Pharma Aktiengesellschaft patents (2012 archive)

Recent patent applications related to Bayer Pharma Aktiengesellschaft. Bayer Pharma Aktiengesellschaft is listed as an Agent/Assignee. Note: Bayer Pharma Aktiengesellschaft may have other listings under different names/spellings. We're not affiliated with Bayer Pharma Aktiengesellschaft, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Bayer Pharma Aktiengesellschaft-related inventors

Date Bayer Pharma Aktiengesellschaft patents (2012 archive) (updated weekly) - BOOKMARK this page
12/13/1217-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseases
10/25/12Fluorinated 2,6-dialkyl-3,5-dicyano-4-(1h-indazol-5-yl)-1,4-dihydropyridines and methods of use thereof
10/18/12Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
10/18/12Stabilised particles comprising 5-methyl-(6s)-tetrahydrofolate
10/18/12Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof
10/11/1217-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases
10/04/12Substituted (heteroarylmethyl)thiohydantoins
09/20/12Compounds for binding and imaging amyloid plaques and their use
09/20/12(heteroarylmethyl) thiohydantoins as anticancer drugs
09/20/12Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
09/20/12Non-polar and polar leaving groups
09/13/1217-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases
08/30/12Substituted piperidines
08/23/12Heteroaryl-substituted piperidines
08/16/12Drug delivery systems (wafer) for pediatric use
08/16/12Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
08/09/12Pellets formulation
07/26/12Radiolabelling method using cycloalkyl groups
07/26/12Medication for oral administration, comprising at least one estrogen and/or at least one gestagen and at least one probiotic bacterial strain
07/26/12Anti-mesothelin immunoconjugates and uses therefor
07/26/1217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseases
07/26/12Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof
07/19/1217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseases
07/19/12Usage of low to medium-pressure liquid chromatography for the purification of radiotracers
07/05/12Pharmaceutical composition for emergency contraception
07/05/12Substituted 1-benzylcycloalkylcarboxylic acids and the use thereof
06/14/1217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
06/14/12Substituted piperidines
06/07/12Buccal application system comprising 17a-estradiol
06/07/12Substituted piperidines
06/07/12Chemical compound and its use
05/31/12Use of high-doses of monomeric contrast medium containing iodine in x-ray diagnostics, in particular in interventional x-ray diagnostics and in radiation therapy assisted by contrast media containing iodine
05/31/12Substituted piperidines
05/24/12Substituted imidazoquinoxalines
05/24/12Substituted 3-(1,2,4-oxadiazol-5-yl)-5-phenylpiperidines
05/24/12Cyclic ketoenols for therapy
05/24/12Substituted sodium 1h-pyrazol-5-olate
05/17/12Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
05/10/12Particles comprising drospirenone encapsulated in a polymer
04/26/12Novel precursor molecules for f-18 labelled pet tracers
04/19/12Sulfonic amide and sulfoximine-substttuted diaryl-dihydropyrimidinones and usage thereof
04/19/1217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
04/12/12Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
04/05/12Transdermal therapeutic system with crystallization-inhibiting protective film (release liner)
03/29/12Low-dose transdermal patches with high drug release
03/08/12Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension
03/01/12Device and use for storage and provision of medicament wafers
03/01/12Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiency
02/23/12Substituted piperidines as par-1 antagonists
02/02/12Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof
01/26/12Sgc stimulators or sgc activators in combination with pde5 inhibitors for the treatment of erectile dysfunction

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Bayer Pharma Aktiengesellschaft in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Bayer Pharma Aktiengesellschaft with additional patents listed. Browse our Agent directory for other possible listings. Page by